Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health

An algorithm may help clinicians recognize patients with bipolar disorder who are misdiagnosed with depression

by Beth Ellwood
February 9, 2022
in Mental Health
Share on TwitterShare on Facebook
Follow PsyPost on Google News

Psychology researchers have developed an algorithm that can predict a patient’s risk of transitioning from a diagnosis of major depression to a diagnosis of bipolar disorder. These findings, published in the journal Translational Psychiatry, may help practitioners identify patients with bipolar disorder who have been misdiagnosed with major depression.

Major depressive disorder (MDD) and bipolar disorder (BD) are common mood disorders with overlapping symptomology. While both conditions are characterized by depressive episodes, a bipolar diagnosis is only met when patients present with at least one manic or hypomanic episode — an episode of extreme energy or elevated feelings.

Researchers have noted that many patients with MDD go on to receive a diagnosis of BD, suggesting they were initially misdiagnosed. There is also evidence that many people with BD wait years before receiving a correct diagnosis, delaying their treatment and increasing their risk of negative outcomes.

Notably, although MDD and BD share clinical features, their recommended treatment differs. While MDD is often treated with antidepressants, there is evidence that these medications can provoke mania among patients with BD. With the aim of helping clinicians identify BD as early as possible, a team of researchers set out to develop a risk assessment algorithm that can help predict which patients with an MDD diagnosis will go on to receive a diagnosis of BD.

Study authors Anastasiya Nestsiarovich and her team designed a model to predict change in diagnosis from MDD to BD over a one-year period. The model was tested across a network of five US patient databases, which included 2,687,578 patients with MDD. Patients who went on to have their diagnosis changed to BD within one year made up the case group, and patients who did not have their diagnosis changed made up the control group.

The final regression model identified seven variables that positively predicted patient transition from MDD to BD within one year — younger age, more severe depression at baseline, the presence of psychosis, the presence of anxiety, thoughts or acts of self-harm, substance misuse, and prior diagnosis with a mental disorder. Three variables negatively predicted transition from MDD to BD — older age, less severe depression at baseline, and pregnancy.

The positive predictor of younger age is in line with evidence that BD tends to present at an earlier age than depression. The positive predictor of depression severity corresponds with research suggesting that patients with BD experience more severe depressive episodes compared to patients with MDD.

The model was then validated across additional datasets in multiple countries. The researchers suggest this algorithm might be a helpful tool for clinicians, allowing them to assign their patients risk scores for diagnosis conversion to BD. “Considering the identified predictors (early onset of depression, presence of severe depression, and psychotic features) might help to promote vigilance among clinicians regarding the possibility of underlying BD diagnosis in depressed patients and encourage them to ask clarifying questions about manic/hypomanic episodes,” Nestsiarovich and her colleagues report.

A notable limitation to the study was that it relied on electronic health records — these records can be limited by missing data and by variations in the criteria used for diagnosis.

The study, “Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study”, was authored by Anastasiya Nestsiarovich, Jenna M. Reps, Michael E. Matheny, Scott L. DuVall, Kristine E. Lynch, Maura Beaton, Xinzhuo Jiang, Matthew Spotnitz, Stephen R. Pfohl, Nigam H. Shah, Carmen Olga Torre, Christian G. Reich, Dong Yun Lee, Sang Joon Son, Seng Chan You, Rae Woong Park, Patrick B. Ryan, and Christophe G. Lambert.

RELATED

Alcohol use disorder may exacerbate Alzheimer’s disease through shared genetic pathways
Mental Health

High-fat fructose diet linked to anxiety-like behavior via disrupted liver-brain communication

August 24, 2025

A new study suggests that non-alcoholic fatty liver disease may contribute to anxiety by promoting brain inflammation and disrupting glutamate regulation. In mice, these changes were triggered by a high-fat fructose diet—and reversed with the plant compound corilagin.

Read moreDetails
Does cannabidiol reduce worry severity or anxiety symptoms? New placebo-controlled study says no
Cannabis

Cannabidiol shows potential to reverse some neuropsychological effects of social stress

August 24, 2025

A non-intoxicating cannabis compound may help protect the brain from the damaging effects of chronic social stress. New research shows cannabidiol reversed stress-related changes in behavior and gene expression in mice exposed to repeated social defeat.

Read moreDetails
Women feel unsafe when objectified—but may still self-sexualize if the man is attractive or wealthy
Autism

A new frontier in autism research: predicting risk in babies as young as two months

August 23, 2025

Clinical trials are underway for an eye-tracking test that may predict autism in infancy, potentially revolutionizing early intervention. Yet the technology also poses difficult questions about medical ethics, parental decision-making, and how predictive data should be handled by insurers.

Read moreDetails
Study suggests that prefrontal cortex damage can have a paradoxical effect on rationality
Mental Health

Cerebellar-prefrontal brain connectivity may shape negative symptoms in psychosis

August 23, 2025

A new study supports the idea that reduced connectivity between the cerebellum and prefrontal cortex contributes to negative symptoms in psychosis. The findings may inform future treatments aimed at improving motivation, memory, and daily functioning.

Read moreDetails
Stress-induced “fixated” eating patterns linked to dopamine disruption, study finds
Addiction

Dopamine-boosting drug enhances self-control and reduces drinking in people with alcohol use disorder

August 22, 2025

A new study suggests the dopamine-boosting drug tolcapone may enhance self-control and reduce alcohol intake in people with alcohol use disorder by increasing activity in brain regions linked to inhibitory control, such as the inferior frontal gyrus and prefrontal cortex.

Read moreDetails
Positive attitudes toward AI linked to problematic social media use
Autism

Scientist who linked autism to chemical and pharmaceutical exposures saw her entire division shut down by RFK Jr.

August 22, 2025

Shortly before publishing a study linking chemical exposure to autism severity in children, a coauthor’s entire research division was eliminated by RFK Jr. The findings raise new concerns about how parental occupational exposures may shape developmental outcomes in autism.

Read moreDetails
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Depression

Antidepressant withdrawal symptoms may be more common and more severe than some studies suggest

August 22, 2025

A new study challenges previous claims that antidepressant withdrawal is rare or mild. Researchers found that more than half of patients report symptoms when discontinuing, suggesting earlier reviews relying on short-term trials may have underestimated the risks.

Read moreDetails
Scientists reveal the disturbing impact of wildfire smoke on key brain cells
Mental Health

Chronic exposure to microplastics impairs blood-brain barrier and damages neurons

August 21, 2025

A new study in Molecular Neurobiology suggests that ingesting microplastics may impair the blood–brain barrier, increase oxidative stress, and damage neurons. Rats exposed to low-density polyethylene microplastics showed signs of neurotoxicity after just a few weeks of exposure.

Read moreDetails

STAY CONNECTED

LATEST

Neuroscientists find evidence of an internal brain rhythm that orchestrates memory

High-fat fructose diet linked to anxiety-like behavior via disrupted liver-brain communication

Study finds Trump and Harris used distinct rhetoric in 2024—but shared more similarities than expected

Evolution may have capped human brain size to balance energy costs and survival

Cannabidiol shows potential to reverse some neuropsychological effects of social stress

Top AI models fail spectacularly when faced with slightly altered medical questions

A new frontier in autism research: predicting risk in babies as young as two months

Cerebellar-prefrontal brain connectivity may shape negative symptoms in psychosis

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy